The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity
Open accessAbstract
Clinicians have access to limited tools that predict which patients with early AKI will progress to more severe stages. In early AKI, urine output after a furosemide stress test (FST), which involves intravenous administration of furosemide (1.0 or 1.5 mg/kg), can predict the development of stage 3 AKI. We measured several AKI biomarkers in our previously published cohort of 77 patients with early AKI who received an FST and evaluated the ability of FST urine output and biomarkers to predict the development of stage 3 AKI ( n =25 [32.5%]), receipt of RRT ( n =11 [14.2%]), or inpatient mortality ( n =16 [20.7%]). With an area under the curve (AUC)±SEM of 0.87±0.09 ( P <0.0001), 2-hour urine output after FST was significantly better than each urinary biomarker tested in predicting progression to stage 3 ( P <0.05). FST urine output was the only biomarker to significantly predict RRT (0.86±0.08; P =0.001). Regardless of the end point, combining FST urine output with individual biomarkers using logistic regression did not significantly improve risk stratification ( Δ AUC, P >0.10 for all). When FST urine output was assessed in patients with increased biomarker levels, the AUC for progression to stage 3 improved to 0.90±0.06 and the AUC for receipt of RRT improved to 0.91±0.08. Overall, in the setting of early AKI, FST urine output outperformed biochemical biomarkers for prediction of progressive AKI, need for RRT, and inpatient mortality. Using a FST in patients with increased biomarker levels improves risk stratification, although further research is needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
Mehta, R. L., Kellum, J. A., Shah, S. V., Molitoris, B. A., Ronco, C., Warnock, D. G., Levin, A., & the Acute Kidney Injury Network (2007) · Critical Care · doi:10.1186/cc5713 · Cited by 7,048
Targeting the KEAP1-NRF2 system to prevent kidney disease progression
Nezu, M., Suzuki, N., & Yamamoto, M. (2017) · American Journal of Nephrology · doi:10.1159/000475890 · Cited by 3,447
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
Kashani, K., Al-Khafaji, A., Ardiles, T., Artigas, A., Bagshaw, S. M., Bell, M., Bihorac, A., Birkhahn, R., Cely, C. M., Chawla, L. S., et al. (2013) · Critical Care · doi:10.1186/cc12503 · Cited by 1,362
Self-citationIndependent Association between Acute Renal Failure and Mortality following Cardiac Surgery
Chertow, G. M., Levy, E. M., Hammermeister, K. E., Grover, F., & Daley, J. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00058-8 · Cited by 1,177
Postoperative Biomarkers Predict Acute Kidney Injury and Poor Outcomes after Adult Cardiac Surgery
Parikh, C. R., Coca, S. G., Thiessen-Philbrook, H., Shlipak, M. G., Koyner, J. L., Wang, Z., Edelstein, C. L., Devarajan, P., Patel, U. D., Zappitelli, M., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121302 · Cited by 754
Self-citationTemporal Changes in Incidence of Dialysis-Requiring AKI
Hsu, R. K., McCulloch, C. E., Dudley, R. A., Lo, L. J., & Hsu, C.-Y. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012080800 · Cited by 521
Validation of Cell-Cycle Arrest Biomarkers for Acute Kidney Injury Using Clinical Adjudication
Bihorac, A., Chawla, L. S., Shaw, A. D., Al-Khafaji, A., Davison, D. L., DeMuth, G. E., Fitzgerald, R., Gong, M. N., Graham, D. D., Gunnerson, K., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201401-0077oc · Cited by 516
Self-citationWijeysundera, D. N., Karkouti, K., Dupuis, J.-Y., Rao, V., Chan, C. T., Granton, J. T., & Beattie, W. S. (2007) · JAMA · doi:10.1001/jama.297.16.1801 · Cited by 469
Chawla, L. S., Davison, D. L., Brasha-Mitchell, E., Koyner, J. L., Arthur, J. M., Shaw, A. D., Tumlin, J. A., Trevino, S. A., Kimmel, P. L., & Seneff, M. G. (2013) · Critical Care · doi:10.1186/cc13015 · Cited by 398
Self-citation
Cited by
Ostermann, M., Bellomo, R., Burdmann, E. A., Doi, K., Endre, Z. H., Goldstein, S. L., Kane-Gill, S. L., Liu, K. D., Prowle, J. R., Shaw, A. D., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.04.020 · Cited by 564
Self-citationLevey, A. S., & James, M. T. (2017) · Annals of Internal Medicine · doi:10.7326/aitc201711070 · Cited by 549
Acute kidney injury in the critically ill: an updated review on pathophysiology and management
Pickkers, P., Darmon, M., Hoste, E., Joannidis, M., Legrand, M., Ostermann, M., Prowle, J. R., Schneider, A., & Schetz, M. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06454-7 · Cited by 549
Biomarkers in acute kidney injury – pathophysiological basis and clinical performance
Schrezenmeier, E. V., Barasch, J., Budde, K., Westhoff, T., & Schmidt‐Ott, K. M. (2017) · Acta Physiologica · doi:10.1111/apha.12764 · Cited by 401
Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption
Kashani, K., Cheungpasitporn, W., & Ronco, C. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0973 · Cited by 289
Metadata
- Authors
- Koyner, J. L., Davison, D. L., Brasha-Mitchell, E., Chalikonda, D. M., Arthur, J. M., Shaw, A. D., Tumlin, J. A., Trevino, S. A., Bennett, M. R., Kimmel, P. L., Seneff, M. G., & Chawla, L. S.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2015-08
- Volume
- 26
- Issue
- 8
- Pages
- 2023-2031
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2165640077
- Cited by
- 283
- References
- 28
- FWCI
- 23.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity. https://app.cochat.ai/papers/10.1681/asn.2014060535
- The paper
- Koyner, J. L., Davison, D. L., Brasha-Mitchell, E., Chalikonda, D. M., Arthur, J. M., Shaw, A. D., Tumlin, J. A., Trevino, S. A., Bennett, M. R., Kimmel, P. L., Seneff, M. G., & Chawla, L. S. (2015). Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2014060535
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.